The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 8
- 8 new
- Median first-year cost
- $367,367
- $3,151,655 in all
- Institutions
- 8
- 8 contact PIs
- Patents
- 2
- from 1 funded project
Awards by fiscal year
Fiscal years 2014 to 2026.
Most frequent institutions
- ARIZONA STATE UNIVERSITY-TEMPE CAMPUS1
- BOSTON CHILDREN'S HOSPITAL1
- CORNELL UNIVERSITY1
- KAISER FOUNDATION RESEARCH INSTITUTE1
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
and 3 other institutions
Most frequent study sections
- Special Emphasis Panel (ZCA1 SRLB-2 (J1))8
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2014 | (PQA2) Exploring the role of sarcopenia in obesity and breast cancer survival1R01CA184953-01 | Caan, Bette J | KAISER FOUNDATION RESEARCH INSTITUTE, CA | First-year cost $629,652 | Study section ZCA1 |
| FY2014 | (PQA1)The Molecular Mechanisms Underlying Effects of Aspirin on Colorectal Cancer1R01CA184820-01 | Dubois, Raymond N. | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | First-year cost $399,474 | Study section ZCA1 |
| FY2014 | (PQA1) The antipsychotic thioridazine protects against medulloblastoma (MB): volu1R01CA185039-01 | Jan, Lily Y | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $386,223 | Study section ZCA1 |
| FY2014 | (PQA3) Smartphone delivered attentional bias modification training for smokers1R01CA184781-01 | Robinson, Jason D | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | First-year cost $370,397 | Study section ZCA1 |
| FY2014 | (PQA2): Escape from breast tumor dormancy: convergence of obesity and menopause1R01CA185530-01 | Moses, Marsha A | BOSTON CHILDREN'S HOSPITAL, MA | First-year cost $364,336 | Study section ZCA1 |
| FY2014 | Cognitive and Emotional Processes of Metaphoric Cancer Communications1R01CA185378-01 | Landau, Mark J. | UNIVERSITY OF KANSAS LAWRENCE, KS | First-year cost $354,290 | Study section ZCA1 |
| FY2014 | (PQA2) Interstitial stiffness as a physicochemical modulator of obesity-induced b1R01CA185293-01 | Fischbach, Claudia | CORNELL UNIVERSITY, NY | First-year cost $345,696 | Study section ZCA1 |
| FY2014 | An Olfactory Method for Controlling Cigarette Craving1R01CA184779-01 | Sayette, Michael Andrew | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | First-year cost $301,587 | Study section ZCA1 |
Patents from its funded projects
2 patents name 1 of the 8 funded projects.
- US 12,241,888 (opens the patent at USPTO, a PDF, in a new tab)PLATFORM FOR ASSESSMENT OF THE TRANSCYTOSIS OF EXTRACELLULAR VESICLES ACROSS ENDOTHELIAL BARRIERS AND USES THEREOFGranted March 4, 2025 to Children's Medical Center CorporationR01CA185530 · BOSTON CHILDREN'S HOSPITAL, MA
- US 11,260,132 (opens the patent at USPTO, a PDF, in a new tab)ENGINEERED LIPOSOMES AS CANCER-TARGETED THERAPEUTICSGranted March 1, 2022 to Children's Medical Center CorporationR01CA185530 · BOSTON CHILDREN'S HOSPITAL, MA
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-12-0.3.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.